McAfee Appoints Craig Boundy as President and Chief Executive Officer
McAfee, a global leader in online protection, today announced the appointment of Craig Boundy as President and Chief Executive Officer, effective August 21, 2024. Boundy, a seasoned executive with over 25 years of leadership experience, joins McAfee from Experian where he served as the global Chief Operating Officer, and previously as CEO for North America.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240715566233/en/
McAfee Appoints Craig Boundy as President and Chief Executive Officer (Photo: Business Wire)
"We are delighted to welcome Craig to McAfee," said Bruce Chizen, Chairman of McAfee’s Board of Directors. "He is an exceptionally talented and accomplished leader with a strong track record of driving high-growth strategies and creating lasting value for customers and partners."
Chizen added, "Craig brings the right mix of experience to McAfee. He's built, led, and transformed companies, has a proven history of strong operational and financial acumen, and is passionate about the customer experience. With his depth of leadership expertise and unwavering commitment to serving customers and inspiring teams globally, Craig is the right leader to take McAfee forward and accelerate our growth opportunities."
Boundy joins McAfee as a highly regarded consumer technology leader. At Experian, he built multi-billion-dollar revenue streams and transformed the company by expanding the business to focus on empowering people to manage their financial lives and digital identities. The businesses he oversaw at Experian have become market leaders and growth engines for the company. Prior to Experian, Boundy held several leadership roles in EMEA and the U.S. including CEO of Logica in the United Kingdom and Chief Operating Officer for Cable & Wireless in Europe, the U.S. and Asia.
"McAfee plays a critical role in the lives of millions of people around the world, every single day," said Craig Boundy, incoming President and Chief Executive Officer, McAfee. "It is an incredible honor and privilege to lead this mission-based company that has become part of the fabric of society thanks to its 30-year history and brand built on trust. I look forward to working with the Board, leadership team, and our exceptionally talented people as we continue to make history by empowering individuals and families to navigate the online world with confidence."
About McAfee
McAfee Corp. is a global leader in online protection for consumers. Focused on protecting people, not just devices, McAfee’s consumer solutions adapt to users’ needs in an always online world, empowering them to live securely through integrated, intuitive solutions that protect their families and communities with the right security at the right moment. For more information, please visit https://www.mcafee.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240715566233/en/
Contacts
Media@McAfee.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sodali & Co Appoints Andrew Benett as Chief Executive Officer14.1.2025 10:00:00 CET | Press Release
Sodali & Co (the ‘firm’ or ‘Sodali’ and formerly Morrow Sodali), a leading global advisory firm, is pleased to announce the appointment of Andrew Benett as Chief Executive Officer, effective immediately. He will be based in New York. Andrew has a 30-year career across global advisory businesses including Global CEO and Chief Strategy Officer at Havas Creative Group, Chief Commercial Officer of Bloomberg Media and CEO and Executive Chair of Harte Hanks Inc., the NASDAQ-listed publishing company. Most recently, Andrew was a Partner at PwC working with clients to deliver organic and inorganic growth, as well as leading corporate strategy initiatives for the firm. He is an acknowledged strategist, author of three business books, and a fellow of the Aspen Institute. Andrew was appointed after a global search following Alvise Recchi stepping down as CEO last September. He joins the firm at an important moment in its development. In the last two years, Sodali has transformed at speed from a s
Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology14.1.2025 10:00:00 CET | Press Release
Bioptimus, the pioneering AI foundation model company, announced today that it has reached a significant funding milestone of $76 million. This total includes a $41 million cash injection, led by Cathay Innovation with participation from prominent investors, including Sofinnova Partners, Bpifrance through its Large Venture Fund, Andera Partners, Hitachi Ventures, Boom Capital Ventures, Pomifer Capital, Sunrise, and angel entrepreneurs Emmanuel Cassimatis and Thomas Wolf. The funding will accelerate Bioptimus’s mission to build the world’s first universal AI foundation model for biology, aimed at revolutionizing research and innovation across the medical, biotech, cosmetic industries, and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250114054102/en/ The company has been building momentum this year, assembling a world-class team, securing access to unique data sources, and successfully releasing its first model, H-Op
Cirium Ascend Consultancy Lands ‘Appraiser of the Year’ Title for the 10th Time14.1.2025 09:00:00 CET | Press Release
Cirium Ascend Consultancy, part of the world’s most trusted source of aviation analytics, Cirium, has once again landed Airline Economics’ prestigious title of ‘Appraiser of the Year’ at an award ceremony last night. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113971776/en/ Cirium awarded 'Appraiser of the Year' (Photo: Business Wire) This marks the tenth win for Cirium Ascend Consultancy, demonstrating its unparalleled expertise within aviation consultancy and underlining its unwavering commitment to excellence, transparency and accuracy. The annual award was presented to Rob Morris, Global Head of Cirium Ascend Consultancy, at the Airline Economics Aviation 100 Global Leaders Awards 2025 in Dublin, Ireland, which celebrates the best companies, individuals and transactions in the aviation finance and leasing sector. 2025’s landmark win makes it the first time a single firm has won the title 10 times, recognising Ciriu
Almirall at the JPMorgan Conference - Entering a New Era of Sustained Growth14.1.2025 07:00:00 CET | Press Release
Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare Conference to provide an update on its business strategy and outlook. The company’s CEO and president Carlos Gallardo will highlight a new era for its business starting in 2025 – forecasting sustained double-digit growth of net sales (CAGR 2023-2030) and a substantial margin expansion, driven by Almirall’s focus on medical dermatology, commercial excellence, and its continued investment in R&D to innovate and advance science. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113044812/en/ Almirall HQ in Barcelona (Photo: Business Wire) Almirall combines the strengthening of its growth drivers, particularly the biologics products, with the continued growth of its broad portfolio of medical dermatology solutions, including Klisyri®, Wynzora®, and Seysara®. Almirall’s commercial excellence has been demons
Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss14.1.2025 07:00:00 CET | Press Release
Galderma (SWX:GALD) announces positive first results from a trial designed to explore the benefits of Restylane® Lyft™ or Contour™ in combination with Sculptra® in patients with medication-driven weight loss with associated facial volume loss.1 Initial three-month interim data from this first-of-its-kind trial suggest that this treatment combination effectively improved facial aesthetic appearance with high patient satisfaction.1 The results will be presented later today at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. Rates of medication-driven weight loss have increased rapidly in recent years and can be associated with facial alterations of variable magnitude.2-4 Patients can find that their skin is less radiant, drier or saggy, and can also observe changes in their facial structure and balance.3,4 Some even find that they appear older than their age.3,4 There are several reasons for these facial alterations including loss of fat, collagen, elastin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom